JP2006505616A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006505616A5 JP2006505616A5 JP2004551909A JP2004551909A JP2006505616A5 JP 2006505616 A5 JP2006505616 A5 JP 2006505616A5 JP 2004551909 A JP2004551909 A JP 2004551909A JP 2004551909 A JP2004551909 A JP 2004551909A JP 2006505616 A5 JP2006505616 A5 JP 2006505616A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- hydrogen
- complex
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42498002P | 2002-11-08 | 2002-11-08 | |
| US60/424,980 | 2002-11-08 | ||
| PCT/US2003/035618 WO2004043380A2 (en) | 2002-11-08 | 2003-11-08 | Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006505616A JP2006505616A (ja) | 2006-02-16 |
| JP2006505616A5 true JP2006505616A5 (enExample) | 2010-05-13 |
| JP4796301B2 JP4796301B2 (ja) | 2011-10-19 |
Family
ID=32312909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004551909A Expired - Fee Related JP4796301B2 (ja) | 2002-11-08 | 2003-11-08 | テクネチウム−９９ｍ及びレニウムで標識した小型作用剤及び組織、臓器及び腫瘍の画像化方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060159617A1 (enExample) |
| EP (1) | EP1567495A4 (enExample) |
| JP (1) | JP4796301B2 (enExample) |
| AU (1) | AU2003290673B2 (enExample) |
| CA (1) | CA2505529C (enExample) |
| WO (1) | WO2004043380A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY179032A (en) | 2004-10-25 | 2020-10-26 | Cancer Research Tech Ltd | Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors |
| UY29177A1 (es) | 2004-10-25 | 2006-05-31 | Astex Therapeutics Ltd | Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos |
| WO2007125321A2 (en) | 2006-04-25 | 2007-11-08 | Astex Therapeutics Limited | Purine and deazapurine derivatives as pharmaceutical compounds |
| BRPI0818533B8 (pt) | 2007-10-11 | 2021-05-25 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto |
| WO2010144891A1 (en) * | 2009-06-13 | 2010-12-16 | President And Fellows Of Harvard College | Compositions and methods for imaging tissues, organs and tumors |
| TWI510241B (zh) | 2010-02-18 | 2015-12-01 | Vtv Therapeutice Llc | 苯基－雜芳基衍生物及其使用方法 |
| ME03589B (me) | 2011-04-01 | 2020-07-20 | Astrazeneca Ab | Terapeutski tretman |
| CN102219818B (zh) * | 2011-05-05 | 2014-01-08 | 江苏省原子医学研究所 | 胸苷衍生物及其制备方法和其作为配体在制备肿瘤显像剂中的应用 |
| MX367640B (es) | 2011-11-30 | 2019-08-29 | Astrazeneca Ab | Tratamiento combinado del cáncer. |
| AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
| US9850183B2 (en) * | 2014-06-27 | 2017-12-26 | Reiley Pharmaceuticals, Inc. | Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging |
| CN120647688A (zh) * | 2024-03-15 | 2025-09-16 | 中国科学院上海药物研究所 | 一种黑色素瘤靶向的放射性药物及其制备与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA852981B (en) * | 1984-04-30 | 1985-11-27 | Univ Johns Hopkins | Brain imaging radiopharmaceuticals |
| US4638051A (en) * | 1984-04-30 | 1987-01-20 | The Johns Hopkins University | Brain imaging radiopharmaceuticals |
| US6241963B1 (en) * | 1995-10-19 | 2001-06-05 | The Trustees Of The University Of Pennsylvania | Dopamine and serotonin transporter ligands and imaging agents |
| US6171576B1 (en) * | 1995-11-03 | 2001-01-09 | Organix Inc. | Dopamine transporter imaging agent |
| US5919934A (en) * | 1997-02-19 | 1999-07-06 | The George Washington University | Compounds, compositions, and methods for cancer imaging and therapy |
| CA2721484A1 (en) * | 1999-05-12 | 2000-11-12 | President And Fellows Of Harvard College | Dopamine transporter imaging agents |
| US6515131B2 (en) * | 2000-02-22 | 2003-02-04 | Biostream Therapeutics, Inc. | Imagining agents for diagnosis of Parkinson's disease |
| CA2407592C (en) * | 2000-04-28 | 2011-03-22 | President And Fellows Of Harvard College | Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
-
2003
- 2003-11-08 US US10/534,225 patent/US20060159617A1/en not_active Abandoned
- 2003-11-08 WO PCT/US2003/035618 patent/WO2004043380A2/en not_active Ceased
- 2003-11-08 AU AU2003290673A patent/AU2003290673B2/en not_active Ceased
- 2003-11-08 JP JP2004551909A patent/JP4796301B2/ja not_active Expired - Fee Related
- 2003-11-08 CA CA2505529A patent/CA2505529C/en not_active Expired - Fee Related
- 2003-11-08 EP EP03783254A patent/EP1567495A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102014969B (zh) | 用于包括灌注成像在内的应用的造影剂 | |
| Karra et al. | 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent | |
| ligan et al. | 99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals | |
| Bailly et al. | Comparison of Immuno-PET of CD138 and PET imaging with 64CuCl2 and 18F-FDG in a preclinical syngeneic model of multiple myeloma | |
| DE69819478T2 (de) | Verfahren zum Nachweis und zur Lokalisierung maligner menschlicher Pankreastumore | |
| Shukla et al. | Dimercaptosuccinic acid: a multifunctional cost effective agent for imaging and therapy | |
| Fang et al. | A novel 18F-labeled agonist for PET imaging of stimulator of interferon gene expression in tumor-bearing mice | |
| CN113105461A (zh) | 七甲基碳菁染料-交联四环胺螯合剂偶联物、复合物及其用途 | |
| CN112870389A (zh) | 一种与放射性金属复合的DZ-1-Lys-DOTA偶联物及应用 | |
| JP2004501093A5 (enExample) | ||
| CA2407592A1 (en) | Small technetium-99m and rhenium labeled agents and methods for imaging tumors | |
| WO2004043380A8 (en) | Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors | |
| Alirezapour et al. | Optimized preparation and preliminary evaluation of [64Cu]–DOTA–trastuzumab for targeting ErbB2/Neu expression | |
| Hunter et al. | Single isomer technetium-99m tamoxifen conjugates | |
| EP2711026A1 (en) | Radioactive fluorine-labeled quinoxaline compound | |
| KR20260040237A (ko) | Psma 표적 방사성 리간드 치료 요법 | |
| US6106804A (en) | Arsenic-72 labeled compounds for tissue specific medical imaging | |
| Lee et al. | Development of 68Ga-SCN-DOTA-Capsaicin as an imaging agent targeting apoptosis and cell cycle arrest in breast cancer | |
| WO2016016272A1 (en) | Macrocyclic complexes, their process of preparation and use as pet imaging agents | |
| Fan et al. | Development of a CD9-Targeted Radiopharmaceutical for Imaging and Radionuclide Therapy in CD9-Positive Glioma | |
| KR20210052435A (ko) | 방사성 이미다조티아디아졸 유도체 화합물 | |
| JP7608378B2 (ja) | 前立腺特異的膜抗原（ｐｓｍａ）リガンド及びその使用 | |
| CN111936173B (zh) | 过渡金属与环戊二烯基阴离子的苯并杂环衍生物的三羰基复合物 | |
| Zhong et al. | Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [68Ga] Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma | |
| AU2015200027B2 (en) | Contrast agents for applications including perfusion imaging |